Fact CheckerSign in

NCT04650269CompletedPhase 4

Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

Implementation of Onsite, Rapid Antiretroviral Therapy (ART) Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

Source: ClinicalTrials.gov · Last updated 8 Jan 2025

Brief summary (registry, in English)

The purpose of this study is to see if providing HIV medicine right away at the IDEA Syringe Services Program will help the participant start and remain in HIV care, including having no detectable HIV in the participant's blood.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
27 (actual)
First submitted
24 Nov 2020
Start date
Mar 2021
Primary completion date
Dec 2023
Lead sponsor
University of Miami
Diseases
HIV
NCT number
NCT04650269

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 27
  • From Mar 2021 to the primary completion date, Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • 1\) Any other comorbidities at the discretion of the investigator

Who the study is looking for

  • Adult (age\>18 years);
  • positive rapid HIV test;
  • ability to provide informed consent;
  • HIV RNA \> 200 copies/ml;
  • creatinine clearance \> 30 mg/dl as measured by serum creatinine;
  • no allergy to bictegravir/emtricitabine/tenofovir alafenamide (BFTAF) as indicated by patient history and self-reported allergies.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Miami
Coordinator of this site? Confirm its status
MiamiUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.